1-7 of 7
Jun Imagawa
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Very Low-Dose Dasatinib Is a Safe and Effective Therapy for Elderly Patients with Newly-Diagnosed Chronic-Phase Chronic Myeloid Leukemia: Results from the Davlec Study, a Single-Arm, Multicenter, Phase 2 Trial

Takashi Kumagai, Kazunori Murai, Hiroshi Ureshino, Hideo Tanaka, Kaichi Nishiwaki, Satoshi Wakita, Koiti Inokuchi, Toshihiro Fukushima, Chikashi Yoshida, Masayuki Mita, Nobuhiko Uoshima, Toru Kiguchi, Jun Aoki, Satoshi Kimura, Kaori Karimata, Kensuke Usuki, Joji Shimono, Yoshiaki Chinen, Junya Kuroda, Yasufumi Matsuda, Kensuke Nakao, Takaaki Ono, Katsumichi Fujimaki, Hirohiko Shibayama, Chisaki Mizumoto, Tomoharu Takeoka, Katsuhiro Io, Takeshi Kondo, Masatomo Miura, Yosuke Minami, Takayuki Ikezoe, Jun Imagawa, Ayako Takamori, Atsushi Kawaguchi, Junichi Sakamoto, Shinya Kimura
Journal: Blood
Blood (2021) 138 (Supplement 1): 3601.
https://doi.org/10.1182/blood-2021-149483
Published: 2021
Journal Articles

Discontinuation Of Dasatinib In Patients With CML Who Have Maintained Complete Molecular Response For At Least One Year: Results From a Prospective Discontinuation (DADI) Trial

Hideo Tanaka, MD, PhD, Jun Imagawa, MD, PhD, Masaya Okada, MD, PhD, Hirohisa Nakamae, MD, PhD, Masayuki Hino, MD, PhD, Kazunori Murai, MD, PhD, Yoji Ishida, M.D., Ph.D., Takashi Kumagai, MD, PhD, Seiichi Sato, MD, Kazuteru Ohashi, MD, PhD, Hisashi Sakamaki, MD, PhD, Hisashi Wakita, MD, PhD, Nobuhiko Uoshima, MD, PhD, Yasunori Nakagawa, MD, Yosuke Minami, MD, PhD, Masahiro Ogasawara, MD, PhD, Tomoharu Takeoka, MD, Hiroshi Akasaka, MD, Satoshi Morita, PhD, Junichi Sakamoto, MD, PhD, Shinya Kimura, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 3998.
https://doi.org/10.1182/blood.V122.21.3998.3998
Published: 2013
Journal Articles

RUNX1/AML1 mutant collaborates with BMI1 overexpression in the development of human and murine myelodysplastic syndromes

Yuka Harada, Daichi Inoue, Ye Ding, Jun Imagawa, Noriko Doki, Hirotaka Matsui, Takashi Yahata, Hiromichi Matsushita, Kiyoshi Ando, Goro Sashida, Atsushi Iwama, Toshio Kitamura, Hironori Harada
Journal: Blood
Blood (2013) 121 (17): 3434–3446.
https://doi.org/10.1182/blood-2012-06-434423
Published: 2013
Includes: Supplemental data
Journal Articles

BMI1 Collaborates with RUNX1/AML1 Mutants in the Development of Human Myelodysplastic Syndrome (MDS) / Acute Myeloid Leukemia (AML)

Hironori Harada, MD, Ye Ding, MD, Jun Imagawa, MD, Takahiko Miyama, MD, Akiro Kimura, MD, Yuka Harada, MD
Journal: Blood
Blood (2011) 118 (21): 275.
https://doi.org/10.1182/blood.V118.21.275.275
Published: 2011
Journal Articles

Clinical and genetic features of therapy-related myeloid neoplasms after chemotherapy for acute promyelocytic leukemia

Brief Report
Jun Imagawa, Yuka Harada, Takeshi Shimomura, Hideo Tanaka, Yoshiko Okikawa, Hideo Hyodo, Akiro Kimura, Hironori Harada
Journal: Blood
Blood (2010) 116 (26): 6018–6022.
https://doi.org/10.1182/blood-2010-06-289389
Published: 2010
Journal Articles

AML1/RUNX1 point mutation possibly promotes leukemic transformation in myeloproliferative neoplasms

Brief Report
Ye Ding, Yuka Harada, Jun Imagawa, Akiro Kimura, Hironori Harada
Journal: Blood
Blood (2009) 114 (25): 5201–5205.
https://doi.org/10.1182/blood-2009-06-223982
Published: 2009
Journal Articles

AML1/RUNX1 Point Mutation Possibly Promotes Leukemic Transformation in Myeloproliferative Disorders.

Jun Imagawa, MD, Yuka Harada, MD, Ye Ding, MD, Akiro Kimura, MD, PhD, Hironori Harada, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 1902.
https://doi.org/10.1182/blood.V114.22.1902.1902
Published: 2009